Skip to main content
Premium Trial:

Request an Annual Quote

NSF Grants Cornell $5.5M for Genome Editing in Rice

NEW YORK (GenomeWeb) — Cornell University announced this week that scientists led by Adam Bogdanove have received a $5.5 million grant from the National Science Foundation for a gene editing project in rice.

The four-year grant will try to provide proof of concept that genome editing can be used to address important measurable agricultural traits in rice, including plant height, yield, disease resistance, and soil acidity tolerance. The scientists will develop a genome editing platform for crop breeding as well as new lines of rice expressing the improved traits.

Bogdanove said that the scientists have already identified particular stretches of DNA as candidates for the quantitative traits of interest.

The project will use data released in 2014 from an international project that sequenced 3,000 different rice genomes from around the world.

The grant did not mention the use of any particular genome editing technologies. Bogdanove is co-creator of transcription activator-like effector nucleases (TALENs); Daniel Voytas, a professor at the University of Minnesota, chief scientific officer at Cellectis Plant Sciences and co-developer of TALENs, is also listed as a co- investigator on the grant. Rice genetics researcher Susan McCouch is also a co-investigator and a professor at Cornell.

In 2011, the NSF awarded researchers at Cornell and the University of California, Riverside $4.8 million to study transposable elements in the rice genome.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more